These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2989678)

  • 1. Results of human T-lymphotropic virus type III test kits reported from blood collection centers--United States, April 22,-May 19, 1985.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(25):375-6. PubMed ID: 2989678
    [No Abstract]   [Full Text] [Related]  

  • 2. Leads from the MMWR. Results of human T-lymphotropic virus type III test kits reported from blood collection centers--United States, April 22 to May 19, 1985.
    JAMA; 1985 Aug; 254(6):741. PubMed ID: 2989567
    [No Abstract]   [Full Text] [Related]  

  • 3. Update: Public Health Service workshop on human T-lymphotropic virus type III antibody testing--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Aug; 34(31):477-8. PubMed ID: 2991728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status report on the acquired immunodeficiency syndrome. Human T-cell lymphotropic virus type III testing. Council on Scientific Affairs.
    JAMA; 1985 Sep; 254(10):1342-5. PubMed ID: 2991616
    [No Abstract]   [Full Text] [Related]  

  • 5. Testing donors of organs, tissues, and semen for antibody to human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 May; 34(20):294. PubMed ID: 2987657
    [No Abstract]   [Full Text] [Related]  

  • 6. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 May; 35(17):284-7. PubMed ID: 3010070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of 3 immuno-enzyme kits for the detection of anti-LAV antibodies. Comparison with confirmation tests. Study Subgroup of the National Blood Transfusion Society].
    Rev Fr Transfus Immunohematol; 1985 Sep; 28(4):325-44. PubMed ID: 3001897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Licensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificity.
    Petricciani JC
    Ann Intern Med; 1985 Nov; 103(5):726-9. PubMed ID: 2996408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of human T-cell lymphotropic virus type 1 among homosexual men in the United States.
    Manns A; Obrams I; Detels R; Diwan A; Ginzburg HM; Goedert JJ; Blattner WA
    N Engl J Med; 1988 Aug; 319(8):516-7. PubMed ID: 2900465
    [No Abstract]   [Full Text] [Related]  

  • 10. Transfusion-associated human T-lymphotropic virus type III/lymphadenopathy-associated virus infection from a seronegative donor--Colorado.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jun; 35(24):389-91. PubMed ID: 3012311
    [No Abstract]   [Full Text] [Related]  

  • 11. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody prevalence in U.S. military recruit applicants.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jul; 35(26):421-4. PubMed ID: 3014305
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress on AIDS.
    FDA Drug Bull; 1985 Oct; 15(3):27-32. PubMed ID: 2996963
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG; Ponce de León S; Ruiz Palacios G; Tinoco JC; Calva JJ; Zamora EE
    Salud Publica Mex; 1986; 28(2):180-5. PubMed ID: 3014666
    [No Abstract]   [Full Text] [Related]  

  • 14. Limitations of enzyme immunoassay tests for detection of HTLV-III/LAV antibodies.
    Lyons SF; McGillivray GM; Coppin AP; Schoub BD
    S Afr Med J; 1985 Oct; 68(8):575-6. PubMed ID: 2996159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-III testing of donor blood imminent; complex issues remain.
    Goldsmith MF
    JAMA; 1985 Jan; 253(2):173-5, 179-81. PubMed ID: 2981368
    [No Abstract]   [Full Text] [Related]  

  • 16. Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Aug; 35(34):540-2, 547-9. PubMed ID: 3018469
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of antibody to HTLV-III by commercial kits.
    O'Shaughnessy MV; Benning BJ; Neumann PW
    CMAJ; 1985 Sep; 133(6):551, 555. PubMed ID: 2992733
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for HTLV-III antibodies--a government blunder?
    Bryan CS
    J S C Med Assoc; 1985 Apr; 81(4):242-4. PubMed ID: 2985870
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HTLV-III testing--a practical solution for blood transfusion services?
    Milner LV; Vorster BJ; Conradie JD; Brain P
    S Afr Med J; 1985 Dec; 68(13):921-2. PubMed ID: 3001948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update: evaluation of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection in health-care personnel--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Sep; 34(38):575-8. PubMed ID: 2993842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.